Detection of Alport Gene Variants in Children and Young People with Persistent Haematuria

Overview

Journal Pediatr Nephrol

Specialties Nephrology
Pediatrics

Date 2024 Sep 30

PMID 39349776

Authors

Natasha Su Lynn Ng

Tomohiko Yamamura

Mohan Shenoy

Helen M Stuart

Rachel Lennon

Affiliations

Soon will be listed here.

Abstract

Background: Genetic kidney disease is an important cause of persistent microscopic haematuria in children and young people. We aimed to determine the frequency of variants in the Alport syndrome genes (COL4A3, COL4A4 or COL4A5) in individuals under 18 years of age presenting with persistent microscopic haematuria to a single specialist centre in the UK over a 10-year period.

Methods: We conducted a retrospective longitudinal study of individuals referred to a tertiary paediatric nephrology service with persistent microscopic haematuria between April 2012 to 2022.

Results: A total of 224 individuals (female 51.8%) were evaluated with persistent microscopic haematuria of greater than 6 months duration. The age at presentation was 7.5 ± 4.3 years (mean ± SD) with a duration of follow-up of 6.8 ± 4.6 years (mean ± SD). Targeted exome sequencing was performed in 134 individuals and 91 (68%) had a pathogenic or likely pathogenic variant in COL4A3, COL4A4 or COL4A5. Only 49.5% of individuals with identified variants had a family history of microscopic haematuria documented and 37.4% (34/91) had additional proteinuria at presentation. COL4A5 was the most common gene affected and missense variants affecting glycine residues were the most common variant type.

Conclusion: Over two-thirds of children and young people who underwent genetic testing had an identifiable genetic basis for their microscopic haematuria and over half did not have a documented family history. Genetic testing should be part of the evaluation of persistent microscopic haematuria despite a negative family history.

References

Jayasinghe K, Stark Z, Kerr P, Gaff C, Martyn M, Whitlam J . Clinical impact of genomic testing in patients with suspected monogenic kidney disease. Genet Med. 2020; 23(1):183-191. PMC: 7790755. DOI: 10.1038/s41436-020-00963-4. View

Alge J, Bekheirnia N, Willcockson A, Qin X, Scherer S, Braun M . Variants in genes coding for collagen type IV α-chains are frequent causes of persistent, isolated hematuria during childhood. Pediatr Nephrol. 2022; 38(3):687-695. DOI: 10.1007/s00467-022-05627-w. View

Groopman E, Marasa M, Cameron-Christie S, Petrovski S, Aggarwal V, Milo-Rasouly H . Diagnostic Utility of Exome Sequencing for Kidney Disease. N Engl J Med. 2018; 380(2):142-151. PMC: 6510541. DOI: 10.1056/NEJMoa1806891. View

Hertz J, Thomassen M, Storey H, Flinter F . Clinical utility gene card for: Alport syndrome - update 2014. Eur J Hum Genet. 2014; 23(9). PMC: 4538213. DOI: 10.1038/ejhg.2014.254. View

Martin A, Williams E, Foulger R, Leigh S, Daugherty L, Niblock O . PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels. Nat Genet. 2019; 51(11):1560-1565. DOI: 10.1038/s41588-019-0528-2. View

Savige J, Storey H, Watson E, Hertz J, Deltas C, Renieri A . Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria. Eur J Hum Genet. 2021; 29(8):1186-1197. PMC: 8384871. DOI: 10.1038/s41431-021-00858-1. View

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J . Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5):405-24. PMC: 4544753. DOI: 10.1038/gim.2015.30. View

Bergstein J, Leiser J, Andreoli S . The clinical significance of asymptomatic gross and microscopic hematuria in children. Arch Pediatr Adolesc Med. 2005; 159(4):353-5. DOI: 10.1001/archpedi.159.4.353. View

Gast C, Pengelly R, Lyon M, Bunyan D, Seaby E, Graham N . Collagen (COL4A) mutations are the most frequent mutations underlying adult focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2015; 31(6):961-70. DOI: 10.1093/ndt/gfv325. View

10.

Vivante A, Afek A, Frenkel-Nir Y, Tzur D, Farfel A, Golan E . Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease. JAMA. 2011; 306(7):729-36. DOI: 10.1001/jama.2011.1141. View

11.

Moreno J, Yuste C, Gutierrez E, Sevillano A, Rubio-Navarro A, Amaro-Villalobos J . Haematuria as a risk factor for chronic kidney disease progression in glomerular diseases: A review. Pediatr Nephrol. 2015; 31(4):523-33. DOI: 10.1007/s00467-015-3119-1. View

12.

Moriniere V, Dahan K, Hilbert P, Lison M, Lebbah S, Topa A . Improving mutation screening in familial hematuric nephropathies through next generation sequencing. J Am Soc Nephrol. 2014; 25(12):2740-51. PMC: 4243343. DOI: 10.1681/ASN.2013080912. View

13.

Kashtan C . Alport Syndrome and Thin Basement Membrane Nephropathy: Diseases Arising from Mutations in Type IV Collagen. Saudi J Kidney Dis Transpl. 2007; 14(3):276-89. View

14.

Gross O, Tonshoff B, Weber L, Pape L, Latta K, Fehrenbach H . A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome. Kidney Int. 2020; 97(6):1275-1286. DOI: 10.1016/j.kint.2019.12.015. View

15.

Gibson J, Huang M, Croos Dabrera M, Shukla K, Rothe H, Hilbert P . Genotype-phenotype correlations for COL4A3-COL4A5 variants resulting in Gly substitutions in Alport syndrome. Sci Rep. 2022; 12(1):2722. PMC: 8854626. DOI: 10.1038/s41598-022-06525-9. View

16.

Cirillo L, Becherucci F . Genetic Testing in Nephrology: Show Your Pedigree!. Kidney360. 2023; 3(12):2148-2152. PMC: 9802562. DOI: 10.34067/KID.0002732022. View

17.

Perez-Palma E, Gramm M, Nurnberg P, May P, Lal D . Simple ClinVar: an interactive web server to explore and retrieve gene and disease variants aggregated in ClinVar database. Nucleic Acids Res. 2019; 47(W1):W99-W105. PMC: 6602488. DOI: 10.1093/nar/gkz411. View

18.

Rheault M, McLaughlin H, Mitchell A, Blake L, Devarajan P, Warady B . COL4A gene variants are common in children with hematuria and a family history of kidney disease. Pediatr Nephrol. 2023; 38(11):3625-3633. DOI: 10.1007/s00467-023-05993-z. View

19.

Lek M, Karczewski K, Minikel E, Samocha K, Banks E, Fennell T . Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016; 536(7616):285-91. PMC: 5018207. DOI: 10.1038/nature19057. View

20.

Malone A, Phelan P, Hall G, Cetincelik U, Homstad A, Alonso A . Rare hereditary COL4A3/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis. Kidney Int. 2014; 86(6):1253-9. PMC: 4245465. DOI: 10.1038/ki.2014.305. View